# Comparison of Bronchodilator Response From Three Different Aerosol Delivery Methods in Patients With COPD Using Hyperpolarized Xe 129 MRI Ventilation Imaging

> **NCT06271408** · PHASE1 · UNKNOWN · sponsor: **Polarean, Inc.** · enrollment: 6 (estimated)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** Albuterol Sulfate, 2.5 Mg/3 mL (0.083%) Inhalation Solution
- **DEVICE:** Vibrating Mesh Nebulizer
- **DEVICE:** Metered Dose Inhaler
- **DEVICE:** Jet Nebulizer

## Key facts

- **NCT ID:** NCT06271408
- **Lead sponsor:** Polarean, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-02
- **Primary completion:** 2024-04
- **Final completion:** 2024-04
- **Target enrollment:** 6 (ESTIMATED)
- **Last updated:** 2024-02-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06271408

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06271408, "Comparison of Bronchodilator Response From Three Different Aerosol Delivery Methods in Patients With COPD Using Hyperpolarized Xe 129 MRI Ventilation Imaging". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06271408. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*